Success Story: NIW Approval in Under 4 Months for A Resident Physician without RFE

Posted by wegreened on February 13, 2026 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“I truly appreciate all the help and clarification Chen Immigration Law Associates has provided. Your team has been indispensable in helping me navigate the complicated process and supporting me as I advocate myself for consideration of NIW."

On January 9^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a a Resident Physician in the Field of Medical Oncology (Approval Notice).

General Field: Medical Oncology

Position at the Time of Case Filing: Resident Physician

Approval Notice Date: January 9^th, 2026

Processing Time: 3 months, 25 days

Case Summary: The central challenge in oncology is translating laboratory discoveries into treatments that work across diverse patient populations. The client's work addresses this challenge directly, analyzing patient-derived tumor tissue to identify biomarkers that can guide individualized therapies for solid tumors while minimizing harmful side effects.

For NIW cases, the most compelling petitions demonstrate not just individual achievement but national importance through concrete patterns: research that addresses critical healthcare priorities, work that other scientists rely upon, and contributions that align with federal initiatives. North America Immigration Law Group (Chen Immigration Law Associates) structured this filing around those signals, emphasizing sustained impact in precision medicine rather than isolated accomplishments.

The case established a clear connection to national priorities. The client’s biomarker-based research directly supports federal goals for advancing early detection and more effective treatments for solid tumors. The petition framed this not as future potential but as ongoing work already generating measurable impact.

We organized the evidence so USCIS could verify both expertise and influence through objective indicators:

Publication record: 9 peer-reviewed journal articles and 7 abstracts (2 of them first-authored)
Scientific influence: 92 citations demonstrating that other researchers are building on this work across oncology, neuroscience, and related fields

The filing also highlighted the client's unique field in medical oncology. With an M.D. from a U.S. medical school and current work as a resident physician at an academic medical center, the client operates at the intersection of clinical practice and laboratory research, translating findings directly into patient care improvements.

USCIS approved the NIW petition in under 4 months without RFE, recognizing a record shaped by sustained research productivity, measurable scientific influence, and clear alignment with national healthcare priorities. We congratulate the client on this milestone and look forward to seeing the continued impact of their work in advancing precision medicine and improving cancer patient outcomes nationwide.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%